BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bukhari MA, Al-Theaby A, Tawhari M, Al-Shaggag A, Pyrke R, Gangji A, Treleaven D, Ribic C. Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation. World J Transplant 2019; 9(6): 134-144 [PMID: 31750090 DOI: 10.5500/wjt.v9.i6.134]
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/134.htm
Number Citing Articles
1
AbdulAziz Batarfi, Haitham Alenezi, Abdulrahman Alshehri, Saud Balelah, Hameedullah Kazim, Mohammed Algthami, Mariam M. Hussain, Nada Alshehri, Rahaf Alsharif, Hadeel Ashour, Mutaz Althobaiti, Shomokh Alotaibi, Helmuth Steinmetz, Christian Foerch. Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional studyJournal of Thrombosis and Thrombolysis 2021; 51(2): 485 doi: 10.1007/s11239-020-02218-0
2
Christian Pfrepper, Adam Herber, Antje Weimann, Roland Siegemund, Cornelius Engelmann, Niklas Aehling, Daniel Seehofer, Thomas Berg, Sirak Petros. Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantationTransplant International 2021; 34(3): 423 doi: 10.1111/tri.13804
3
Alexandra L. Bixby, Alicia B. Lichvar, David Salerno, Jeong M. Park. Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic reviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(1): 28 doi: 10.1002/phar.2485
4
David M. Salerno, Megan E. Thornberg, Nicholas W. Lange, Jessica Hedvat, Hilary Robbins, Robert S. Brown, Douglas L. Jennings, Jenna Scheffert. Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipientsClinical Transplantation 2021; 35(12) doi: 10.1111/ctr.14396
5
Mohammad F. Zaitoun, Mahmoud El Sheikh, Abdullah S. Al Faifi, Ahmed W. Mahedy, Weam El Nazer, Hany M. El Hennawy. The Use of Non–Vitamin K Antagonist Oral Anticoagulants in Post-Kidney Transplantation, Single-Center ExperienceTransplantation Proceedings 2021; 53(10): 2918 doi: 10.1016/j.transproceed.2021.09.042
6
Nikolina Basic-Jukic, Vesna Furic-Cunko, Ivana Juric. Novel Oral Anticoagulants in Renal Transplant Recipients: A Retrospective Cohort StudyPRILOZI 2020; 41(2): 49 doi: 10.2478/prilozi-2020-0032
7
Claudia Stöllberger, Josef Finsterer. Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patientsExpert Review of Clinical Pharmacology 2021; 14(5): 569 doi: 10.1080/17512433.2021.1908124
8
Mikołaj Młyński, Mikołaj Sajek, Zbigniew Heleniak, Alicja Dębska-Ślizień. Safety of Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Patients with Chronic Kidney Disease and Kidney Transplant RecipientsTransplantology 2022; 3(3): 208 doi: 10.3390/transplantology3030022
9
Kathrine Parker, Janette Chu, Muir Morton, Shiv Bhutani, Michael Picton, Sandip Mitra, Jecko Thachil. Can direct oral anticoagulants be used in kidney transplant recipients?Clinical Transplantation 2021; 35(12) doi: 10.1111/ctr.14474